The invention discloses a method for producing cobra snake poison
protein (CT) and
phospholipase A2 (PLA2) in a baculovirus-
insect expression
system. The method comprises the following steps: separating
DNA (Deoxyribonucleic Acid) sequences expressing CT and PLA2 mature peptides from the poison gland of a cobra by using a RT-PCR (Reverse Transcription-
Polymerase Chain Reaction) method, and constructing
insect virus expression vectors BM-CT and BM-PLA2; transferring a vector carrying a
target gene and an empty vector into Sf9
insect cells to obtain
virus particles; infecting the cells by using the
virus particles, detecting the expression of the
target protein through SDS-PAGE (
Sodium Dodecyl Sulfate-
Polyacrylamide Gel Electrophoresis)
electrophoresis, and purifying CT and PLA2 from
cell lysis supernatant by using a Ni column
elution method. The
analgesic activities of CT and PLA2 are detected by using the abdominal
constriction test of mice. As proved by a detection result, the twisting times of the mouse in a CT treatment group are remarkably less than that of a PLA2 treatment group and a control group, indicating that the obtained CT has
analgesic activity and has a better effect than PLA2; the twisting times of the mouse in the PLA2 treatment group are remarkably less than that of the control group, indicating that the obtained PLA2 also has
analgesic activity. The related CT and PLA2 proteins can be taken as analgesics for application to the development and application of clinical medical analgesics as well as the research of foundation
medicine.